$8.50
At close: Sep 27, 11:27 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Eiger BioPharmaceuticals Inc in recent months.
Browse guidance and forecast on all stocks.